Use of botulinum toxin in Meige's disease.

Abstract

Four patients with severe Meige's disease (blepharospasm-oromandibular dystonia) have been treated, after having given an informed consent, by local injections of purified botulinum toxin type "A". Previous systemic therapy with anticholinergics, dopamine antagonists and other drugs had been unsuccessful in all these subjects. Each patient was treated by saline solution injected with the same method as botulinum toxin, just once. The self-evaluation of patients and the clinical evaluation that some of us- unaware of the kind of therapy which had been performed- gave to the symptoms on the basis of videotapes, for each session of injection, showed that the injections of botulinum toxin are effective in the treatment of such disorder. The duration of the beneficial effect was slightly shorter in these patients than in patients with blepharospasm treated by the same method.

• Authors: S Maurri, S Brogelli, G Alfieri, F Barontini
• Journal: Rivista di neurologia (Riv Neurol) 1988 Nov-Dec Vol. 58 Issue 6 Pg. 245-8 ISSN: 0035-6344 [Print] Italy
• PMID: 3247565 (Publication Type: Case Reports, Clinical Trial, Controlled Clinical Trial, Journal Article)

Chemical References

• Botulinum Toxins

Topics

• Aged
• Basal Ganglia Diseases (drug therapy)
• Botulinum Toxins (therapeutic use)
• Double-Blind Method
• Drug Evaluation
• Female
• Humans
• Male
• Meige Syndrome (drug therapy)
• Middle Aged